COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT01877811
Brief Title: Study of RXDX-105, Potent RET Inhibitor in Patients With Advanced Lung Cancer and Other Solid Tumors

First Submitted : May 6, 2013
First Submitted that Met QC Criteria : June 11, 2013
First Posted : June 14, 2013 (Estimate)

Last Update Submitted that Met QC Criteria : April 24, 2019
Last Update Posted : April 25, 2019